TREA

88377509 - JALDURZO

Follow

Information

  • Trademark
  • 88377509
  • Serial Number
    88377509
  • Registration Number
    6161316
  • Filing Date
    April 09, 2019
    5 years ago
  • Registration Date
    September 29, 2020
    3 years ago
  • Transaction Date
    May 02, 2024
    21 days ago
  • Status Date
    September 29, 2020
    3 years ago
  • Published for Opposition Date
    July 14, 2020
    3 years ago
  • Location Date
    September 29, 2020
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    MARTIN, LIEF ANDREW
  • Attorney Docket Number
    114353.00070
    Attorney Name
    Michael J. Leonard
    Law Office Assigned Location Code
    M30
  • Owners
Information
Mark Drawing Code
4
Mark Identification
JALDURZO
Case File Statements
  • GS0051: pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies sold as an ingredient of pharmaceuticals for the treatment of treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis
  • GS0421: research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies
Case File Event Statements
  • 5/6/2019 - 5 years ago
    4 - ASSIGNED TO LIE Type: ALIE
  • 4/12/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 4/26/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/28/2019 - 5 years ago
    3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 5/7/2019 - 5 years ago
    5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 6/19/2019 - 4 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/19/2019 - 4 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/19/2019 - 4 years ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/19/2019 - 4 years ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 12/1/2019 - 4 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/1/2019 - 4 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/2/2019 - 4 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/4/2019 - 4 years ago
    13 - FINAL REFUSAL WRITTEN Type: CNFR
  • 12/4/2019 - 4 years ago
    14 - FINAL REFUSAL E-MAILED Type: GNFR
  • 12/4/2019 - 4 years ago
    15 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 5/28/2020 - 3 years ago
    16 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 6/8/2020 - 3 years ago
    22 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/8/2020 - 3 years ago
    23 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/28/2020 - 3 years ago
    17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/29/2020 - 3 years ago
    18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/8/2020 - 3 years ago
    19 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 6/8/2020 - 3 years ago
    20 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 6/8/2020 - 3 years ago
    21 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 7/14/2020 - 3 years ago
    25 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/14/2020 - 3 years ago
    26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/29/2020 - 3 years ago
    27 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/24/2024 - 29 days ago
    28 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 5/1/2024 - 22 days ago
    29 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 6/24/2020 - 3 years ago
    24 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP